BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 2988126)

  • 1. Immunogenicity of synthetic peptides from circumsporozoite protein of Plasmodium falciparum.
    Ballou WR; Rothbard J; Wirtz RA; Gordon DM; Williams JS; Gore RW; Schneider I; Hollingdale MR; Beaudoin RL; Maloy WL
    Science; 1985 May; 228(4702):996-9. PubMed ID: 2988126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine.
    Young JF; Hockmeyer WT; Gross M; Ballou WR; Wirtz RA; Trosper JH; Beaudoin RL; Hollingdale MR; Miller LH; Diggs CL
    Science; 1985 May; 228(4702):958-62. PubMed ID: 2988125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmodium falciparum: elicitation by peptides and recombinant circumsporozoite proteins of circulating mouse antibodies inhibiting sporozoite invasion of hepatoma cells.
    Hollingdale MR; Ballou WR; Aley SB; Young JF; Pancake S; Miller LH; Hockmeyer WT
    Exp Parasitol; 1987 Jun; 63(3):345-51. PubMed ID: 2438152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A linear peptide containing minimal T- and B-cell epitopes of Plasmodium falciparum circumsporozoite protein elicits protection against transgenic sporozoite challenge.
    Calvo-Calle JM; Oliveira GA; Watta CO; Soverow J; Parra-Lopez C; Nardin EH
    Infect Immun; 2006 Dec; 74(12):6929-39. PubMed ID: 17030584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent efforts in the development of a sporozoite vaccine against human malaria.
    Hockmeyer WT; Dame JB
    Adv Exp Med Biol; 1985; 185():233-45. PubMed ID: 3907309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a sporozoite malaria vaccine.
    Nussenzweig V; Nussenzweig RS
    Am J Trop Med Hyg; 1986 Jul; 35(4):678-88. PubMed ID: 2425647
    [No Abstract]   [Full Text] [Related]  

  • 7. Human and murine CD4 T cell epitopes map to the same region of the malaria circumsporozoite protein: limited immunogenicity of sporozoites and circumsporozoite protein.
    Dontfraid F; Cochran MA; Pombo D; Knell JD; Quakyi IA; Kumar S; Houghten RA; Berzofsky JA; Miller LH; Good MF
    Mol Biol Med; 1988 Dec; 5(3):185-96. PubMed ID: 2468986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural localization of Plasmodium falciparum circumsporozoite protein in newly invaded hepatoma cells.
    Aley SB; Atkinson CT; Aikawa M; Maloy WL; Hollingdale MR
    J Parasitol; 1987 Dec; 73(6):1241-5. PubMed ID: 2830392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunity to malaria and naturally acquired antibodies to the circumsporozoite protein of Plasmodium falciparum.
    Hoffman SL; Wistar R; Ballou WR; Hollingdale MR; Wirtz RA; Schneider I; Marwoto HA; Hockmeyer WT
    N Engl J Med; 1986 Sep; 315(10):601-6. PubMed ID: 3526148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple non-repeated epitopes on the circumsporozoite protein of Plasmodium knowlesi.
    Vergara U; Gwadz R; Schlesinger D; Nussenzweig V; Ferreira A
    Mol Biochem Parasitol; 1985 Mar; 14(3):283-92. PubMed ID: 2581134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
    Calle JM; Nardin EH; Clavijo P; Boudin C; Stüber D; Takacs B; Nussenzweig RS; Cochrane AH
    J Immunol; 1992 Oct; 149(8):2695-701. PubMed ID: 1401909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental basis for the development of a synthetic vaccine against Plasmodium falciparum malaria sporozoites.
    Nussenzweig V; Nussenzweig R
    Ciba Found Symp; 1986; 119():150-63. PubMed ID: 2426050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a 6.5-day minimum exoerythrocytic cycle for Plasmodium falciparum in humans and confirmation that immunization with a synthetic peptide representative of a region of the circumsporozoite protein retards infection.
    Murphy JR; Baqar S; Davis JR; Herrington DA; Clyde DF
    J Clin Microbiol; 1989 Jul; 27(7):1434-7. PubMed ID: 2671011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum.
    Dame JB; Williams JL; McCutchan TF; Weber JL; Wirtz RA; Hockmeyer WT; Maloy WL; Haynes JD; Schneider I; Roberts D
    Science; 1984 Aug; 225(4662):593-9. PubMed ID: 6204383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of liposomes as potential carriers of vaccines: applications to cholera toxin and human malaria sporozoite antigen.
    Alving CR; Richards RL; Moss J; Alving LI; Clements JD; Shiba T; Kotani S; Wirtz RA; Hockmeyer WT
    Vaccine; 1986 Sep; 4(3):166-72. PubMed ID: 3532603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and immunological characterization of 104-mer and 102-mer peptides corresponding to the N- and C-terminal regions of the Plasmodium falciparum CS protein.
    Roggero MA; Filippi B; Church P; Hoffman SL; Blum-Tirouvanziam U; Lopez JA; Esposito F; Matile H; Reymond CD; Fasel N
    Mol Immunol; 1995 Dec; 32(17-18):1301-9. PubMed ID: 8643099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary structure of the 175K Plasmodium falciparum erythrocyte binding antigen and identification of a peptide which elicits antibodies that inhibit malaria merozoite invasion.
    Sim BK; Orlandi PA; Haynes JD; Klotz FW; Carter JM; Camus D; Zegans ME; Chulay JD
    J Cell Biol; 1990 Nov; 111(5 Pt 1):1877-84. PubMed ID: 2229177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of the repetitive and nonrepetitive peptide regions of the divergent CS protein of Plasmodium knowlesi.
    Sharma S; Gwadz RW; Schlesinger DH; Godson GN
    J Immunol; 1986 Jul; 137(1):357-61. PubMed ID: 3086454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recognition of synthetic 104-mer and 102-mer peptides corresponding to N- and C-terminal nonrepeat regions of the Plasmodium falciparum circumsporozoite protein by sera from human donors.
    Lopez JA; Roggero MA; Duombo O; Gonzalez JM; Tolle R; Koita O; Arevalo-Herrera M; Herrera S; Corradin G
    Am J Trop Med Hyg; 1996 Oct; 55(4):424-9. PubMed ID: 8916800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites.
    Zavala F; Tam JP; Masuda A
    J Immunol Methods; 1986 Oct; 93(1):55-61. PubMed ID: 3534091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.